Human medicines European public assessment report (EPAR): Viekirax, ombitasvir,paritaprevir,ritonavir, Date of authorisation: 14/01/2015, Revision: 28, Status: Withdrawn (authorisation)

Human medicines European public assessment report (EPAR): Exviera, dasabuvir, Date of authorisation: 14/01/2015, Revision: 26, Status: Withdrawn (authorisation)

PSUSA/00010583/202401

Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR): Zynlonta, loncastuximab tesirine, Date of authorisation: 20/12/2022, Revision: 3, Status: Authorised

Quality and equivalence of locally applied, locally acting cutaneous products - Scientific guideline

Human medicines European public assessment report (EPAR): Benlysta, belimumab, Date of authorisation: 13/07/2011, Revision: 35, Status: Authorised

Human medicines European public assessment report (EPAR): Cresemba, isavuconazole, Date of authorisation: 15/10/2015, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Imatinib Teva, imatinib, Date of authorisation: 07/01/2013, Revision: 20, Status: Authorised

Organisation chart: Veterinary Medicines